SCHEMBL5730671

SCHEMBL5730671

C=C1CCC(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8764171 0.83
SCHEMBL3882447 0.81
SCHEMBL22341177 0.81 NOS3 (0.35)
SCHEMBL18597825 0.79 ALDH1A1 (0.33)
SCHEMBL14104396 0.76 CYP2A6 (0.30)
SCHEMBL17874213 0.74
SCHEMBL1633779 0.69
SCHEMBL23570009 0.69 CYP2C9 (0.42)
SCHEMBL12556375 0.69
SCHEMBL23570010 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021186166-A1 GLP RECEPTOR AGONISTS HEPTARES THERAPEUTICS LIMITED (GB) 2021-09-23 WO disclosed
EP-3771017-A1 ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE DAIKIN INDUSTRIES, LTD. (JP) 2021-01-27 EP disclosed
EP-3694041-A1 ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY CELL, AND MODULE Daikin Industries, Ltd. (JP) 2020-08-12 EP disclosed
EP-2285979-B2 HYBRIDIZATION COMPOSITIONS AND METHODS DAKO DENMARK AS (DK) 2020-02-19 EP disclosed
EP-2594569-B1 ENTECAVIR SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF ZHEJIANG AUSUN PHARMACEUTICAL CO LTD (CN) 2019-03-20 EP disclosed
EP-1318811-B1 CYCLOPENTYL MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO INC (US) 2006-08-30 EP disclosed
US-3946081-A OXIDATION CATALYSTS, GROUP V, VI, OR VII OXIDES BAYER AKTIENGESELLSCHAFT (DT) 1976-03-23 US disclosed